Congenital Hypodysfibrinogenemia

Also Known As:

Hypodysfibrinogenemia, Congenital

Networked: 8 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Hemic and Lymphatic Diseases: 6
- Hematologic Diseases: 3366
  - Hemorrhagic Disorders: 702
    - Afibrinogenemia: 436
      - Congenital Hypodysfibrinogenemia: 8
  - Blood Coagulation Disorders: 167
    - Inherited Blood Coagulation Disorders: 74
      - Afibrinogenemia: 436
        Congenital Hypodysfibrinogenemia: 8
    - Coagulation Protein Disorders: 1
      - Afibrinogenemia: 436
        Congenital Hypodysfibrinogenemia: 8
Congenital, Hereditary, and Neonatal Diseases and Abnormalities: 933
- Inborn Genetic Diseases: 11939
  - Inherited Blood Coagulation Disorders: 74
    - Afibrinogenemia: 436
      - Congenital Hypodysfibrinogenemia: 8

Related Diseases

1.	Venous Thrombosis (Deep-Vein Thrombosis)
2.	Factor XI Deficiency (Hemophilia C)

Experts

1.	Casini, Alessandro: 1 article (01/2021)
2.	Durual, Stéphane: 1 article (01/2021)
3.	Gay, Valérie: 1 article (01/2021)
4.	Goodyer, Matthew: 1 article (01/2021)
5.	Marchi, Rita: 1 article (01/2021)
6.	Neerman-Arbez, Marguerite: 1 article (01/2021)
7.	Vilar, Rui: 1 article (01/2021)
8.	Nie, Longjian: 1 article (01/2020)
9.	Peng, Yan: 1 article (01/2020)
10.	Qin, Cong: 1 article (01/2020)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Congenital Hypodysfibrinogenemia:

1.	Fibrinogen (Factor I)FDA Link 01/01/2021 - "Congenital hypodysfibrinogenemia is a rare fibrinogen disorder, defined by decreased levels of a dysfunctional fibrinogen. " 08/01/2018 - "Congenital hypodysfibrinogenemia associated with a novel deletion of three residues (γAla289_Asp291del) in fibrinogen." 03/01/2002 - "Fibrinogen Córdoba: biochemical characterization of a new congenital hypodysfibrinogenemia." 08/15/1975 - "Fibrinogen Giessen II appears to be a congenital hypodysfibrinogenemia with abnormality of fibrinogen resulting in delayed coagulation and a retarded fibrinogenolysis rate." 01/01/2020 - "Both congenital hypodysfibrinogenemia and factor XI deficiency are rare coagulopathies caused by mutations within the fibrinogen and F11 genes, respectively. "
2.	Tissue Plasminogen Activator (Alteplase)FDA Link 08/01/1991 - "Fibrinogen date: congenital hypodysfibrinogenemia associated with decreased binding of tissue-plasminogen activator."
3.	Fibrinopeptide BIBA 12/01/1983 - "Fibrinogen Baltimore II: congenital hypodysfibrinogenemia with delayed release of fibrinopeptide B and decreased rate of fibrinogen synthesis."
4.	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/01/2020 - "To investigate the pathogenesis of combined congenital hypodysfibrinogenemia with factor XI (FXI) deficiency in a Chinese family, coagulation assays, FXI activity (the 1-stage method), fibrinogen activity (the Clauss method), and antigen (prothrombin time [PT]-derived method) were performed. "
5.	AntigensIBA 01/01/2020 - "To investigate the pathogenesis of combined congenital hypodysfibrinogenemia with factor XI (FXI) deficiency in a Chinese family, coagulation assays, FXI activity (the 1-stage method), fibrinogen activity (the Clauss method), and antigen (prothrombin time [PT]-derived method) were performed. "
6.	fibrinogen Baltimore IIIBA 12/01/1983 - "A congenital hypodysfibrinogenemia, fibrinogen Baltimore II, was found in a young asymptomatic Caucasian female. " 12/01/1983 - "Fibrinogen Baltimore II: congenital hypodysfibrinogenemia with delayed release of fibrinopeptide B and decreased rate of fibrinogen synthesis."